Orange Book product · Brand (NDA)
PREZISTA
DARUNAVIR
At a glance
Dec 16, 2011
Approved
Brand (NDA)
Application
Not listed
TE code
2
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 16, 2011
14 yr 9 mo ago
Today
Patent 7700645 expires
Listed drug substance patent expiration.
Dec 26, 2026
in 6 mo
Patent 7700645*PED expires
Listed listed patent expiration.
Jun 26, 2027
in 1 yr
Pharmaceutical detail
Active ingredient
DARUNAVIR
Strength
100MG/ML
Dosage form
SUSPENSION
Route
ORAL
TE code
Not listed
Application
NDA 202895
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2008PREZISTABrand (NDA)
NDA 021976 · JANSSEN PRODS
- 2025DARUNAVIRGeneric (ANDA)
ANDA 202136 · MYLAN
- 2025DARUNAVIRGeneric (ANDA)
ANDA 216168 · ANNORA PHARMA
- 2023DARUNAVIRGeneric (ANDA)
ANDA 214085 · ZYDUS LIFESCIENCES
- 2023DARUNAVIRGeneric (ANDA)
ANDA 212493 · AMNEAL
- 2023DARUNAVIRGeneric (ANDA)
ANDA 210677 · AUROBINDO PHARMA LTD
- 2023DARUNAVIRGeneric (ANDA)
ANDA 206288 · CIPLA
- 2023DARUNAVIRGeneric (ANDA)
ANDA 211578 · DR REDDYS
- 2023DARUNAVIRGeneric (ANDA)
ANDA 215389 · MSN
- 2023DARUNAVIRGeneric (ANDA)
ANDA 202083 · HETERO LABS LTD III
- 2022DARUNAVIRGeneric (ANDA)
ANDA 202073 · LUPIN
- 2017DARUNAVIRGeneric (ANDA)
ANDA 202118 · TEVA PHARMS USA
Listed patents (2)
| Patent | Expires | In | Type |
|---|---|---|---|
| 7700645 | Dec 26, 2026 | in 6 mo | SubstanceProduct |
| 7700645*PED | Jun 26, 2027 | in 1 yr |

